It's signed. Two dates. Do not run one cliff.
On Wednesday, September 2, 2026, the President signed H.R. 6500, the Continuing Appropriations and Extensions Act, 2027. Congress.gov records it as Public Law No: 119-103. Presented that day. Became law that day.
That signature is the fact yesterday's desk watch was waiting on. It is not a uniform move of the hemp cliff to December 11.
Enrolled section 2019 is now statute:
Until December 11, 2026, the amendments made by section 781 of division B of Public Law 119-37 (7 U.S.C. 1639o note) shall only apply with respect to products described in paragraphs (1)(C)(ii)(I) and (1)(C)(iv)(I) of section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) (as amended by such section 781).
Two clocks. Both are live law.
Clock 1 - November 12, 2026, still hits
The carve-out did not move. Intermediate and final hemp-derived cannabinoid products that contain cannabinoids not capable of being naturally produced by a Cannabis sativa L. plant still leave the hemp definition on November 12, 2026. That is 7 U.S.C. section 1639o (1)(C)(ii)(I) and (1)(C)(iv)(I), as added by P.L. 119-37 section 781.
Do not tell a buyer "synthetics got 29 days." They did not. Do not collapse this with (ii)(II) / (iv)(II) - cannabinoids the plant can produce that were synthesized or manufactured outside the plant. Those outside-the-plant conversions are in the delayed bucket, not the November 12 bucket.
FDA still has not published the 90-day cannabinoid lists and container guidance required by P.L. 119-37 section 781(3). The Nov 12 carve-out does not wait for that list. If you are mapping SKUs without it, do it with counsel, against the statute's structure, not against a Discord name for "synthetic."
Clock 2 - December 11, 2026, for the rest of section 781
The rest of the new hemp definition waits until December 11. That includes the 0.3 percent total-THC standard (with THCA), the 0.4 milligram combined total per innermost container, the viable-seed exclusion, industrial-hemp inclusion, and the outside-the-plant conversions in (ii)(II) and (iv)(II).
December 11 is also the day this CR funds the government through. A 29-day delay of most of section 781 is not a new hemp statute. The same fight returns inside the next must-pass funding bill.
Do not write a single "the cliff moved." Do not date a full-spectrum or THCA catalog to December 11 and leave a non-natural cannabinoid SKU on the same letter.
Dual-map, now as law, not as a scenario
Track A (November 12, live): intermediate and final products with cannabinoids a Cannabis sativa L. plant cannot naturally produce. Pull, relabel, or get counsel on structure before that date. FDA's unpublished list is not a stay.
Track B (December 11, live for everything else in section 781): total-THC including THCA, 0.4 mg per container, viable seeds, outside-the-plant conversions of naturally occurring cannabinoids, industrial hemp as defined. Ship these against current 2018-farm-bill hemp until December 11 unless a later Public Law says otherwise.
Two columns. Neither is a screenshot of Roll 286. Both come from P.L. 119-103 section 2019 read against 7 U.S.C. section 1639o.
What this signature does not change
Texas DSHS Schedule I for manufactured non-delta-9 isomers remains in force. No filed TRO. Do not reopen Texas. Virginia's 2 mg total THC per package has been in force since August 15. Square's October 15 hemp/CBD catalog pull is still processor policy. North Carolina H328 is still not enacted. CRS IF13136 is still the August 17 version and does not yet reflect P.L. 119-103 - do not treat that In Focus as the signed clock.
Personal thoughts
Yesterday the honest sentence was "watch the desk." Today the honest sentence is "two dates, both law." The screenshot economy will pick December 11 and bury November 12 in a footnote. That is how a non-natural SKU gets a December letter and a November seizure.
We map SKUs to the enrolled carve-out, not to a headline that "Congress delayed hemp." The delay is real for most of section 781. The carve-out is also real. FDA still has not told you which cannabinoids it thinks the plant can make. That gap is now an operator problem with a November 12 deadline, not a reason to pretend the carve-out is theoretical.
Map the SKU on Thynk Compliance Platform on both clocks. Do not let December overwrite November for the (ii)(I) / (iv)(I) products.
Disclaimer. This article is operator analysis from Thynk Industries, not legal advice, not a lobbying communication, and not a prediction sold as a later statute. It is the personal-thoughts lane of a company that tracks enrolled Public Laws against 7 U.S.C. section 1639o. A White House signing recap, an unpublished FDA list, a CRS In Focus that has not been updated since August 17, and a language model are not substitutes for P.L. 119-103 section 2019. Counsel should read that section against P.L. 119-37, Division B, section 781 before anyone restocks, reprices, or tells a retailer there is only one federal date.
Sources (primary first)
H.R. 6500, 119th Cong. Latest action 09/02/2026 Became Public Law No: 119-103. Tracker: Became Law. https://www.congress.gov/bill/119th-congress/house-bill/6500
Enrolled bill, SEC. 2019. https://www.congress.gov/bill/119th-congress/house-bill/6500/text/enr
White House, "Congressional Bill H.R. 6500 Signed into Law," September 2, 2026. https://www.whitehouse.gov/briefings-statements/2026/09/congressional-bill-h-r-6500-signed-into-law/
7 U.S.C. section 1639o (prelim.), including the section 781 amendment note for (1)(C)(ii)(I) and (1)(C)(iv)(I). https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title7-section1639o&num=0&edition=prelim
P.L. 119-37, Division B, section 781 (7 U.S.C. section 1639o note), including the unpublished FDA list mandate in section 781(3).
Texas DSHS Consumable Hemp Program (Schedule I / July 31, 2026 language still live). https://www.dshs.texas.gov/consumable-hemp-program
FDA cannabis news table (lists still unpublished). https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
Live 2 Sep desk-watch (do not reprint): https://www.thynk.guru/post/both-chambers-acted-watch-the-desk
Comments